GB202105950D0 - Analytical HPLC - Google Patents

Analytical HPLC

Info

Publication number
GB202105950D0
GB202105950D0 GBGB2105950.6A GB202105950A GB202105950D0 GB 202105950 D0 GB202105950 D0 GB 202105950D0 GB 202105950 A GB202105950 A GB 202105950A GB 202105950 D0 GB202105950 D0 GB 202105950D0
Authority
GB
United Kingdom
Prior art keywords
analytical hplc
hplc
analytical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2105950.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB2105950.6A priority Critical patent/GB202105950D0/en
Publication of GB202105950D0 publication Critical patent/GB202105950D0/en
Priority to PCT/EP2022/061004 priority patent/WO2022229155A1/en
Priority to KR1020237040178A priority patent/KR20240000562A/ko
Priority to ES22725757T priority patent/ES3050308T3/es
Priority to CA3217818A priority patent/CA3217818A1/en
Priority to PL22725757.3T priority patent/PL4330662T3/pl
Priority to US18/557,528 priority patent/US20240302338A1/en
Priority to EP22725757.3A priority patent/EP4330662B1/en
Priority to IL307946A priority patent/IL307946A/en
Priority to AU2022264815A priority patent/AU2022264815A1/en
Priority to JP2023565467A priority patent/JP2024518319A/ja
Priority to CN202280031268.4A priority patent/CN117222890A/zh
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/0093—Radioactive materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
    • G01N2030/8845—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds involving halogenated organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8859—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
GBGB2105950.6A 2021-04-26 2021-04-26 Analytical HPLC Ceased GB202105950D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2105950.6A GB202105950D0 (en) 2021-04-26 2021-04-26 Analytical HPLC
CN202280031268.4A CN117222890A (zh) 2021-04-26 2022-04-26 分析型hplc
CA3217818A CA3217818A1 (en) 2021-04-26 2022-04-26 Analytical hplc
KR1020237040178A KR20240000562A (ko) 2021-04-26 2022-04-26 분석용 hplc
ES22725757T ES3050308T3 (en) 2021-04-26 2022-04-26 Analytical hplc
PCT/EP2022/061004 WO2022229155A1 (en) 2021-04-26 2022-04-26 Analytical hplc
PL22725757.3T PL4330662T3 (pl) 2021-04-26 2022-04-26 Analityczna hplc
US18/557,528 US20240302338A1 (en) 2021-04-26 2022-04-26 Analytical hplc
EP22725757.3A EP4330662B1 (en) 2021-04-26 2022-04-26 Analytical hplc
IL307946A IL307946A (en) 2021-04-26 2022-04-26 Analytical hplc
AU2022264815A AU2022264815A1 (en) 2021-04-26 2022-04-26 Analytical hplc
JP2023565467A JP2024518319A (ja) 2021-04-26 2022-04-26 分析用ｈｐｌｃ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2105950.6A GB202105950D0 (en) 2021-04-26 2021-04-26 Analytical HPLC

Publications (1)

Publication Number Publication Date
GB202105950D0 true GB202105950D0 (en) 2021-06-09

Family

ID=76193425

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2105950.6A Ceased GB202105950D0 (en) 2021-04-26 2021-04-26 Analytical HPLC

Country Status (12)

Country Link
US (1) US20240302338A1 (enExample)
EP (1) EP4330662B1 (enExample)
JP (1) JP2024518319A (enExample)
KR (1) KR20240000562A (enExample)
CN (1) CN117222890A (enExample)
AU (1) AU2022264815A1 (enExample)
CA (1) CA3217818A1 (enExample)
ES (1) ES3050308T3 (enExample)
GB (1) GB202105950D0 (enExample)
IL (1) IL307946A (enExample)
PL (1) PL4330662T3 (enExample)
WO (1) WO2022229155A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
CN119688861A (zh) * 2024-11-29 2025-03-25 中国辐射防护研究院 一种生物样本中18f-psma-1007放化纯的液相色谱分析方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300280A (en) * 1992-02-14 1994-04-05 Mallinckrodt Medical, Inc. Stabilized radiopharmaceutical kits
ES2398393T3 (es) * 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
JP4942953B2 (ja) * 2005-06-30 2012-05-30 サントリーホールディングス株式会社 プロシアニジンの分析方法
US8214159B2 (en) * 2008-12-04 2012-07-03 Siemens Medical Solutions Usa, Inc. Apparatus and method for automated quality control
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
EP2450332A1 (en) * 2010-10-22 2012-05-09 Bayer Pharma Aktiengesellschaft Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
CN104718299B (zh) * 2012-08-13 2024-02-06 通用医院公司 用于线粒体复合物i的定量定位的系统和方法
GB201303830D0 (en) * 2013-03-04 2013-04-17 Univ Glasgow Methods,unit and device relating to the manufacture,processing,synthesising or screening of radiopharmaceutical compositions
GB201418893D0 (en) * 2014-10-23 2014-12-10 Univ Hull Monolithic body
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
CN111333638A (zh) * 2020-03-17 2020-06-26 四川大学华西医院 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用

Also Published As

Publication number Publication date
KR20240000562A (ko) 2024-01-02
EP4330662A1 (en) 2024-03-06
EP4330662B1 (en) 2025-09-03
PL4330662T3 (pl) 2025-11-12
JP2024518319A (ja) 2024-05-01
IL307946A (en) 2023-12-01
ES3050308T3 (en) 2025-12-19
CN117222890A (zh) 2023-12-12
US20240302338A1 (en) 2024-09-12
CA3217818A1 (en) 2022-11-03
WO2022229155A1 (en) 2022-11-03
EP4330662C0 (en) 2025-09-03
AU2022264815A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
EP3668977A4 (en) HPLC ANALYTICAL PROCESSES
DK4305181T3 (en) Minimal nefrin-promotor
GB2600833B (en) Dual-comb spectrometry
CA196956S (en) Onesie
CA207519S (en) Smartglasses
CA207516S (en) Smartglasses
CA207517S (en) Smartglasses
CA204810S (en) Playard
CA199411S (en) Handshower
PL4330662T3 (pl) Analityczna hplc
CA200872S (en) Nighstand
GB201910777D0 (en) Analytical method
CA206631S (en) Mandoline
GB202104683D0 (en) Analytical HPLC
GB2603239B (en) Autosampler
GB202215978D0 (en) Analytical HPLC
CA218801S (en) Autosampler carousel
CA204263S (en) Brushguard
CA198107S (en) Protractor-ruler
GB202202384D0 (en) Feature n
GB202113947D0 (en) Chromatography column
GB202209846D0 (en) One
CA207518S (en) Smartglasses
CA204055S (en) Spiralizer
CA201360S (en) Débardeur

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)